The use of heteroatom-substituted porphyrins in bioorganic and materials chemistry requires the ability to position a variety of substituents in a controlled manner about the porphyrin periphery. We describe a rational route to trans -AB 2 C-type porphyrins bearing one oxygen atom (N 3 O) or one sulfur atom (N 3 S) in a designated location in the porphyrin core. The synthesis involved four stages: (1) Acid-catalyzed condensation of a furyl- or thienylcarbinol in excess pyrrole afforded the aryl-substituted furyl- or thienylpyrromethane in high yield. (2) Treatment of the furyl- or thienylpyrromethane with an acid chloride catalyzed by SnCl 4 or AlCl 3 afforded the corresponding diketo product. (3) Reduction with NaBH 4 in alcoholic solvents gave the furyl- or thienylpyrromethanediols. (4) Reaction of a furylpyrromethanediol, thienylpyrromethanediol, or dipyrromethanediol with a dipyrromethane in a one-flask process of condensation followed by oxidation gave the corresponding porphyrin. Reaction conditions previously identified to minimize scrambling in a dipyrromethane−aldehyde condensation were found to be effective in this application. Thus, reaction with 10 mM reactants in acetonitrile at 0 °C containing BF 3 ·Et 2 O and NH 4 Cl followed by oxidation with DDQ resulted in the desired porphyrin (10−20% yields) without acidolysis. In this manner, N 3 O-, N 3 S-, or N 4 -porphyrins bearing 5-( p -iodophenyl), 15-[4-(2-(trimethylsilyl)ethynyl)phenyl], and 10,20-di- p -tolyl groups have been made. This set of trans-substituted porphyrin building blocks is expected to be useful in the synthesis of biomimetic energy transduction systems.
No takes yet. Share an insight, caveat, or question.
Cho et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: